![Cui Ping Gu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cui Ping Gu
Directeur/Bestuurslid bij
Cullgen, Inc.
Profiel
Cui Ping Gu is currently working as a Director at Cullgen, Inc. Prior to this, Dr. Gu served as a Non-Executive Director at QuantumPharm, Inc. from 2018 to 2024.
Dr. Gu also worked as a Project Manager at Eli Lilly & Co. Dr. Gu holds a doctorate degree from Shanghai Jiao Tong University, which was conferred in 2007.
Additionally, Dr. Gu obtained an undergraduate degree from Shanghai Jiao Tong University in 2002.
Actieve functies van Cui Ping Gu
| Bedrijven | Functie | Begin |
|---|---|---|
Cullgen, Inc.
 Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Directeur/Bestuurslid | - |
Eerdere bekende functies van Cui Ping Gu
| Bedrijven | Functie | Einde |
|---|---|---|
| XTALPI HOLDINGS LIMITED | Directeur/Bestuurslid | 30-10-2024 |
Opleiding van Cui Ping Gu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
92
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Shanghai Jiao Tong University
 Shanghai Jiao Tong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cullgen, Inc.
Cullgen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that focused on discovery and development of targeted protein degrader and DAC therapies for cancer and inflammatory & pain diseases | Health Technology |
QuantumPharm, Inc.
 QuantumPharm, Inc. BiotechnologyHealth Technology Operates as an investment holding company that engages in provision of drug discovery and intelligent automation solutions | Health Technology |
